| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | ARACARI BIOSCIENCES, INC | 5270 CALIFORNIA AVE STE 300 | IRVINE | CA | 92617-3231 | ORANGE | USA | R43HL164221 | A Vascularized Bone Marrow Model for In Vitro Testing of Drug Toxicity | 000 | 1 | NIH | 5/14/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $294,998 ) |
| | 2023 | 2023 | ARACARI BIOSCIENCES INC | 5270 CALIFORNIA AVE | IRVINE | CA | 92617-3231 | ORANGE | USA | R43NS132676 | A Vascularized Blood-Brain Barrier Model for In Vitro Testing of Drug and Immunotherapy Delivery | 000 | 1 | NIH | 4/24/2023 | $294,998 |
|
| Issue Date FY: 2022 ( Subtotal = $314,018 ) |
| | 2022 | 2022 | ARACARI BIOSCIENCES, INC. | 5270 CALIFORNIA AVE STE 300 | IRVINE | CA | 92617-3231 | ORANGE | USA | R43HL164221 | A Vascularized Bone Marrow Model for In Vitro Testing of Drug Toxicity | 000 | 1 | NIH | 3/22/2022 | $314,018 |
|
|
